NCT05522491 2025-12-11
Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
Hebei Medical University Fourth Hospital
Phase 2 Not yet recruiting
Hebei Medical University Fourth Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute
European Institute of Oncology
Beidahuang Industry Group General Hospital